| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1474-4422(05)70249-0 |
| P698 | PubMed publication ID | 16297843 |
| P50 | author | Ted Michael Burns | Q66672198 |
| P2093 | author name string | P James B Dyck | |
| Clement J Michet | |||
| Greg A Schaublin | |||
| P2860 | cites work | Damage occurs early in systemic vasculitis and is an index of outcome | Q73471968 |
| Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis | Q73471972 | ||
| Infliximab efficiency in refractory Wegener's granulomatosis | Q73817838 | ||
| Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity | Q73939175 | ||
| Development of anti-TNF therapy for rheumatoid arthritis | Q74187188 | ||
| Mechanisms of tissue injury in vasculitic neuropathies | Q74249163 | ||
| Superficial peroneal nerve/peroneus brevis muscle biopsy in vasculitic neuropathy | Q74298364 | ||
| Epineurial microvasculitis in proximal diabetic neuropathy | Q74467438 | ||
| Subclinical peripheral nerve involvement in patients with rheumatoid arthritis | Q74776732 | ||
| Neurological manifestations of malignant and non-malignant dysglobulinaemias | Q77425567 | ||
| Serologic and clinical response to treatment of systemic vasculitis and associated autoimmune disease with intravenous immunoglobulin | Q78095704 | ||
| Polyarteritis nodosa | Q78288429 | ||
| Efficacy of the anti-TNF-alpha antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients | Q78328605 | ||
| PERIPHERAL NEUROPATHY ASSOCIATED WITH RHEUMATOID ARTHRITIS. A CLINICAL AND ELECTRODIAGNOSTIC STUDY OF 70 CONSECUTIVE RHEUMATOID ARTHRITIS PATIENTS | Q78409484 | ||
| Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20 | Q78728686 | ||
| Expression of matrix metalloproteinases in vasculitic neuropathy | Q79249450 | ||
| Vasculitis of the nervous system | Q80141120 | ||
| The clinical spectrum of necrotizing angiopathy of the peripheral nervous system | Q93604797 | ||
| Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years | Q24674079 | ||
| Neurology of the vasculitides and connective tissue diseases | Q24679901 | ||
| P-ANCA vasculitic neuropathy with 12-year latency between onset of neuropathy and systemic symptoms | Q24794202 | ||
| Nomenclature of systemic vasculitides. Proposal of an international consensus conference | Q29616304 | ||
| Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial | Q30816918 | ||
| Neurologic complications of leukemia | Q33185226 | ||
| Paraproteinemia and neuropathy | Q33790303 | ||
| Cryoglobulinemic vasculitis | Q33806419 | ||
| Standardized neurologic evaluations of 128 patients with Wegener granulomatosis | Q33953953 | ||
| The antineutrophil cytoplasmic antibody-associated vasculitides | Q33979253 | ||
| Etanercept plus standard therapy for Wegener's granulomatosis | Q33984596 | ||
| Neurological involvement in Wegener's granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic | Q34061539 | ||
| Nerve granulomas and vasculitis in sarcoid peripheral neuropathy: a clinicopathological study of 11 patients | Q34114057 | ||
| Neuromuscular complications of connective tissue diseases | Q34141653 | ||
| Therapeutic antibodies for human diseases at the dawn of the twenty-first century | Q34168125 | ||
| Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients | Q34295946 | ||
| Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients | Q34372279 | ||
| The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical review | Q34381902 | ||
| Receptor for advanced glycation endproduct (RAGE)-mediated nuclear factor-kappaB activation in vasculitic neuropathy | Q44916068 | ||
| Short-term corticosteroids then lamivudine and plasma exchanges to treat hepatitis B virus-related polyarteritis nodosa | Q44930000 | ||
| Wegener Granulomatosis: An Analysis of 158 Patients | Q45267316 | ||
| Treatment of mononeuropathy multiplex in hepatitis C virus and cryoglobulinemia | Q45753465 | ||
| Painful lumbosacral plexopathy with elevated erythrocyte sedimentation rate: A treatable inflammatory syndrome | Q46495198 | ||
| Primary systemic vasculitis: clinical features and mortality | Q47863831 | ||
| Neurological manifestations of chronic hepatitis C. | Q48146944 | ||
| Nonsystemic vasculitic neuropathy | Q48223349 | ||
| Clinicopathological features of Churg-Strauss syndrome-associated neuropathy | Q48254163 | ||
| Matrix metalloproteinases-9 and -2 in secondary vasculitic neuropathies | Q48429959 | ||
| Vasculitic neuropathy. A clinical and pathological study | Q48652489 | ||
| Nomenclature and classification of vasculitis: plus ça change, plus c'est la même chose | Q48797565 | ||
| Vasculitis confined to peripheral nerves | Q48898511 | ||
| Hepatitis B-associated polyarteritis nodosa in Alaskan Eskimos: clinical and epidemiologic features and long-term follow-up. | Q50556617 | ||
| Long-term follow-up study of periarteritis nodosa. | Q53794085 | ||
| An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients. | Q54302140 | ||
| Cryoglobulinemia | Q56907690 | ||
| Peripheral neuropathy with necrotizing vasculitis in rheumatoid arthritis | Q59400174 | ||
| Vasculitic neuropathy | Q67494311 | ||
| The Bruns-Garland syndrome (diabetic amyotrophy). Revisited 100 years later | Q68061259 | ||
| Treatment of systemic vasculitis with pooled intravenous immunoglobulin | Q68299017 | ||
| The peripheral neuropathy of necrotizing arteritis: a clinicopathological study | Q69831408 | ||
| Treatment of cryoglobulinemic neuropathy with alpha-interferon | Q71041766 | ||
| Pulmonary function in patients receiving long-term low-dose methotrexate | Q71089903 | ||
| Corticosteroids plus pulse cyclophosphamide and plasma exchanges versus corticosteroids plus pulse cyclophosphamide alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome patients with factors predicting poor prognosis. A prospect | Q71561244 | ||
| Nonsystemic vasculitic mononeuropathy multiplex, cryoglobulinemia, and hepatitis C | Q71828922 | ||
| Nerve biopsy findings in different patterns of proximal diabetic neuropathy | Q72411565 | ||
| High-dose intravenous immunoglobulin therapy in chronic progressive lumbosacral plexopathy | Q72776654 | ||
| Neurologic manifestations of systemic vasculitis. A retrospective and prospective study of the clinicopathologic features and responses to therapy in 25 patients | Q72907786 | ||
| Churg-Strauss syndrome | Q73029473 | ||
| Sensory ataxic dominant neuropathy associated with polyarteritis nodosa | Q73074182 | ||
| Treatment of idiopathic lumbosacral plexopathy with intravenous immunoglobulin | Q73089790 | ||
| Peripheral neuropathy in systemic lupus erythematosus: pathomorphological features and distribution pattern of matrix metalloproteinases | Q73096460 | ||
| Microvasculitis and ischemia in diabetic lumbosacral radiculoplexus neuropathy | Q73276595 | ||
| Vasculitic neuropathies | Q73449785 | ||
| Necrotizing peripheral nerve vasculitis | Q34446208 | ||
| Diabetic and nondiabetic lumbosacral radiculoplexus neuropathies: new insights into pathophysiology and treatment | Q34587469 | ||
| ANCA-positive vasculitis | Q34713022 | ||
| Severe exacerbation of hepatitis C-associated vasculitic neuropathy following treatment with interferon alpha: a case report and literature review | Q34737065 | ||
| Update on diabetic neuropathy. | Q34915857 | ||
| 15. Vasculitis | Q35068349 | ||
| Kawasaki-like syndromes and other vasculitic syndromes in HIV-infected patients. | Q35180753 | ||
| Paraneoplastic neurologic syndromes: approaches to diagnosis and treatment | Q35190256 | ||
| Intravenous immunoglobulins in peripheral neuropathy associated with vasculitis | Q35552224 | ||
| Rituximab induces remission in refractory HCV associated cryoglobulinaemic vasculitis | Q35552273 | ||
| The peripheral nerve complications of human immunodeficiency virus (HIV) infection | Q35565265 | ||
| Recent advances in vascular inflammation: C-reactive protein and other inflammatory biomarkers | Q35606994 | ||
| Periarteritis nodosa; a critical review | Q35665319 | ||
| Treatment of hepatitis B virus-related polyarteritis nodosa: two case reports and a review of the literature. | Q35715856 | ||
| B cells as therapeutic targets for rheumatic diseases | Q35753658 | ||
| Intravenous immunoglobulin in autoimmune neuromuscular diseases | Q35776725 | ||
| Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system | Q35842193 | ||
| Sensory neuropathy in vasculitis: a clinical, pathologic, and electrophysiologic study | Q35886307 | ||
| Non-systemic vasculitic neuropathy | Q35887726 | ||
| Primary and secondary vasculitic neuropathy | Q36087113 | ||
| Classification and diagnostic criteria in systemic vasculitis | Q36109367 | ||
| How can relapses be detected and prevented in primary systemic small-vessel vasculitides? | Q36109389 | ||
| Efficacy and safety of rituximab in type II mixed cryoglobulinemia | Q40566328 | ||
| Cytomegalovirus infection in systemic necrotizing vasculitis: causative agent or opportunistic infection? | Q40609687 | ||
| Hepatitis C infection, cryoglobulinemia, and vasculitic neuropathy. Treatment with interferon alfa: case report and literature review | Q40616618 | ||
| Clinical findings and prognosis of polyarteritis nodosa and Churg-Strauss angiitis: a study in 165 patients | Q40784645 | ||
| Subacute diabetic proximal neuropathy | Q41669709 | ||
| A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies | Q42163521 | ||
| A role for hepatitis C virus infection in type II cryoglobulinemia | Q42983385 | ||
| Peginterferon alfa-2a in patients with chronic hepatitis C. | Q43001243 | ||
| Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis | Q43041401 | ||
| Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus | Q43049410 | ||
| Successful treatment of severe rheumatoid vasculitis by infliximab | Q43050448 | ||
| Safety and efficacy of TNFalpha blockade in relapsing vasculitis | Q43051121 | ||
| Acute autonomic and sensory neuropathy after interferon alpha-2b therapy for chronic hepatitis C. | Q43071289 | ||
| Microscopic polyangiitis and polyarteritis nodosa: how and when do they start? | Q43491385 | ||
| Effectiveness of TNF-alpha blockade with infliximab in refractory Wegener's granulomatosis | Q43828598 | ||
| Neurologic complications associated with hepatitis C virus infection | Q43882326 | ||
| Hepatitis B associated fulminant polyarteritis nodosa: successful treatment with pulse cyclophosphamide, prednisolone and lamivudine following emergency surgery | Q43976471 | ||
| Maintenance of remission with leflunomide in Wegener's granulomatosis | Q44507162 | ||
| Nonsystemic vasculitic neuropathy: insights from a clinical cohort | Q44578338 | ||
| Infliximab improves endothelial dysfunction in systemic vasculitis: a model of vascular inflammation | Q44810026 | ||
| Mycophenolate mofetil for remission maintenance in the treatment of Wegener's granulomatosis | Q44839339 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Vasculitic neuropathy | Q85812811 |
| P304 | page(s) | 853-865 | |
| P577 | publication date | 2005-12-01 | |
| P1433 | published in | Lancet Neurology | Q15755067 |
| P1476 | title | An update on the classification and treatment of vasculitic neuropathy | |
| P478 | volume | 4 |
| Q33413841 | Cranial nerve palsy in Wegener's granulomatosis--lessons from clinical cases |
| Q38398833 | Diagnosis and therapeutic options for peripheral vasculitic neuropathy |
| Q38106010 | How to recognise and treat peripheral nervous system vasculitis |
| Q24244144 | Immunosuppressive treatment for non-systemic vasculitic neuropathy |
| Q24246358 | Immunosuppressive treatment for non-systemic vasculitic neuropathy |
| Q36484399 | Immunotherapies for Neurological Manifestations in the Context of Systemic Autoimmunity |
| Q53403448 | Isolated severe vasculitic neuropathy revealing sarcoidosis. |
| Q53105387 | Nerve biopsy in Indian patients with mononeuropathy multiplex of undetermined etiology. |
| Q37835738 | Nerve biopsy: requirements for diagnosis and clinical value |
| Q37590659 | Neurological complications of chronic kidney disease |
| Q36226668 | Peripheral neuropathy in Wegener's granulomatosis, Churg-Strauss syndrome and microscopic polyangiitis |
| Q42362072 | Polyarteritis nodosa presenting as peripheral vascular disease and acute limb ischemia |
| Q58092005 | Technically successful ultrasound-guided percutaneous sural nerve needle biopsy in a patient with indeterminate peripheral neuropathy |
| Q36971106 | The use of nerve and muscle biopsy in the diagnosis of vasculitis: a 5 year retrospective study. |
| Q56882317 | Vasculitic neuropathies |
| Q84897597 | [Extra-articular manifestations of rheumatoid arthritis] |
| Q82647018 | [Vasculitis of the nervous system in infectious diseases] |
Search more.